Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
This gene ("ENSG00000270382") represents a **pseudogene** related to *SH3 domain-binding glutamic acid-rich protein like 3*, meaning it shares significant sequence homology to the functional SH3BGRL3 gene but is not predicted to encode a functional protein[2][4]. Pseudogenes arise via duplication or retrotransposition and often contain sequence disruptions such as frameshifts or premature stop codons[2][4]. In rare cases, pseudogenes are capable of producing functional non-coding RNAs, including those that can act as microRNA decoys, small interfering RNAs, or regulatory elements for other genes, but there is no evidence that this pseudogene has such activity[2][4]. It is not considered a therapeutic target and is not associated with interacting drugs, mechanisms of action, or biomarkers. Pseudogenes can introduce confusion in genome annotation and may sometimes be misclassified in sequence databases[2]. This entry is a pseudogene, not a functional target, receptor, enzyme, or therapeutic entity; there is no protein product nor known physiological function, thus it should not be considered a valid therapeutic target[2][4]. If you are seeking information on a functional, protein-coding target, refer instead to SH3BGRL3 (SH3 domain-binding glutamic acid-rich-like protein 3), which is the bona fide gene and protein[1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on SH3 domain-binding glutamic acid-rich protein like 3 pseudogene.